Annual Drug Patent Expirations for AURYXIA
Auryxia is a drug marketed by Keryx Biopharms and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug.
Drug patent litigation for AURYXIA.
This drug has one hundred and twenty-eight patent family members in twenty-six countries.
The generic ingredient in AURYXIA is ferric citrate. One supplier is listed for this compound. Additional details are available on the ferric citrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
